| |
Where does the information in IMS Knowledge Link come from?
Sales information for products, countries, therapies and companies
The sales information is compiled using the IMS MIDAS' global
analysis system, which captures the dynamics of pharmaceutical activity
in more than 80 countries.
Growth in sales is measured in constant dollars, enabling
analyses without the influence of fluctuating currency exchange rates.
Pharmaceutical sales figures include prescription and some
over-the-counter data, and represent manufacturer prices.
The relevant underlying source of information is IMS World Review.
Information for drugs in research and development
The R&D editorial team works closely with companies and
relies on their feedback to obtain up-to-date information. Their
activities are as follows:
- Asking companies to update information on drugs in their pipeline
- Carrying out company interviews, using drug-specific questionnaires
- Reviewing press releases and annual reports
Also at:
- Scientific conferences
- Analyst briefings
- IMS local links with companies
- Company R&D days
- Company investor conferences
- Review journals, posters and conference abstracts
- Regulatory data from the various regulatory agencies such as the US FDA, EU EMEA and the Japanese NHI
IMS Knowledge Link only shows drugs that are
in active development; i.e. where progress has been reported within the
last three years.
The relevant underlying source of information is IMS LifeCycle R&D Focus.
Non-numeric company information
A team of in-house editors exploit their knowledge of the
healthcare industry and their diverse backgrounds in medicine,
pharmacology, chemistry and languages to provide critical analyses of a
company's business strategies.
Internal and external sources of
information are utilised to build up the most comprehensive picture of
the key companies on the market today, including:
- Interviews with key personnel such as CEO,
head of R&D, in major corporations, plus interviews with senior
personnel in several biotech/specialty pharmaceutical companies
- Conferences, companies' annual reports, and press releases
- Specialist publications, internet
- Stockbrokers/analysts reports
The relevant underlying source of information is IMS Company Profiles.
Patent information
Patent information compiled by IMS
emanates from official patent documentation relating to projects in
development, either a patent application or a granted patent document.
The IMS patent experts work closely with CAS, Chemical Abstract
Services, to maintain up-to-date records within the service. They are
also in close contact with patent attorneys at local country levels and
work with official patent journals to ensure that the latest amendments
to the patent laws are reflected in IMS Knowledge Link.
Secondary resources, such as the Orange Book, official country
patent journals, online and internet services are also monitored by the
team to update information on patent legal status, lapsing, granting,
extensions, SPCs, pediatric exclusivities, marketing exclusivities,
orphan drug status.
The relevant underlying source of information is IMS LifeCyle Patent Focus.
IMS R&D News
Sources of information for R&D News are the same as the ones used for the R&D information.
Reuters Healthcare News
Reuters is the largest international multi-media
news agency, reporting extensively from around the world on topics
ranging from financial markets to general and political news. IMS
Knowledge Link features news relating to pharmaceutical companies
as well as the country markets news that may be relevant.
How often is the information updated?
Annual or quarterly-updated
sales information for products, countries, therapies and companies
The sales information is updated on 1st April each year and it reflects
the previous year's sales. The next release is on 1st April 2004,
showing world sales figures recorded from 1st January to 31st December
2003.
The user has the option to obtain more pertinent sales information,
as all sales figures can also be updated on a quarterly basis, providing
world sales for 12 months from the previous quarter.
Weekly information for drugs
in research and development
This information is updated on a weekly basis to ensure that pipeline
developments are captured as adequately as possible.
Monthly non-numeric
company information
This information is updated on a monthly basis as follows:
- up to ten companies each month will feature brand new information covering all aspects of the company's performance
- any major news on a company will be
included on an ad-hoc basis, often covering one particular aspect such
as a new product launch or an acquisition.
Monthly patent information
This information is updated on a monthly basis to monitor new patent
filings as well as news relating to potential litigations.
Weekly R&D News
This information is updated on a weekly basis to report on the latest
phase changes, launches, approvals as well as licensing offers.
Daily Reuters Healthcare industry news
This information is updated on a daily basis to ensure that the
latest industry news is as timely as possible.
|
TAKE THE TOUR
